At a Glance
Dosage
Only in Efavirenz
smoked
| Level | Dose |
|---|---|
| Common | 600–1800 mg |
Only in 1cP-LSD
oral
| Level | Dose |
|---|---|
| Threshold | 15 µg |
| Light | 25–75 µg |
| Common | 75–150 µg |
| Strong | 150–300 µg |
| Heavy | 300 µg |
Duration
Only in Efavirenz
smoked
Peak
Afterglow
Onset1 min – 5 min
Peak1 hrs – 2 hrs
Afterglow6 hrs – 12 hrs
Only in 1cP-LSD
oral
Total: 8 hrs – 12 hrsEffects
Safety
Interaction: Efavirenz + 1cP-LSD
Low Risk & Synergy
Cross-tolerance exists; effects compound
Efavirenz — Dangerous Interactions
No dangerous interactions recorded.
1cP-LSD — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between Efavirenz and 1cP-LSD?
Efavirenz is classified as a Psychedelic (Benzoxazine) while 1cP-LSD is classified as a Psychedelic (Lysergamides). They share 34 effects in common, with 7 effects unique to Efavirenz and 43 unique to 1cP-LSD.
Is it safe to combine Efavirenz and 1cP-LSD?
The interaction between Efavirenz and 1cP-LSD is classified as "Low Risk & Synergy". Cross-tolerance exists; effects compound Always research interactions thoroughly before combining any substances.
Which is stronger, Efavirenz or 1cP-LSD?
Efavirenz and 1cP-LSD are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.